Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
Details for Australian Patent Application No. 2002341921 (hide)
International Classifications
Event Publications
27 February 2003 Complete Application Filed
Priority application(s): 60/327,132 04.10.01 US
26 June 2003 Application Open to Public Inspection
Published as AU-B-2002341921
31 May 2007 Application Accepted
Published as AU-B-2002341921
14 June 2007 Corrigenda
Applications Accepted - Name Index Under the name Merck & Co., Inc., Application No. 2002341921, under INID (72) correct the co-inventor name to read Reger, Thomas
27 September 2007 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
4 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser